
    
      This is a multi-center, outpatient, double-blind, placebo-controlled, single treatment,
      sequential dose escalation study designed to evaluate the safety, tolerability and
      preliminary efficacy of single doses of MYOBLOC versus placebo for the treatment of
      sialorrhea in Parkinson's disease patients, lasting approximately 20 weeks.
    
  